OTC Markets EXMKT - Delayed Quote USD

IntelGenx Technologies Corp. (IGXT)

0.1700
0.0000
(0.00%)
At close: May 19 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,051
1,039
950
1,535
1,544
Cost of Revenue
1,745
1,733
1,858
2,256
1,477
Gross Profit
-694
-694
-908
-721
67
Operating Expense
9,413
8,797
8,505
7,261
6,331
Operating Income
-10,107
-9,491
-9,413
-7,982
-6,264
Net Non Operating Interest Income Expense
-2,071
-1,584
-1,277
-1,336
-780
Other Income Expense
--
1,148
--
--
--
Pretax Income
-11,030
-9,927
-10,690
-9,318
-7,044
Tax Provision
--
0
0
-6
0
Net Income Common Stockholders
-11,030
-9,927
-10,690
-9,312
-7,044
Diluted NI Available to Com Stockholders
-11,030
-9,927
-10,690
-9,312
-7,044
Basic EPS
-0.06
-0.06
-0.07
-0.07
-0.07
Diluted EPS
-0.06
-0.06
-0.07
-0.07
-0.07
Basic Average Shares
174,657.5400
174,654.5650
164,746.0540
137,003.3130
108,440.8880
Diluted Average Shares
174,657.5400
174,654.5650
164,746.0540
137,003.3130
108,440.8880
Total Operating Income as Reported
-10,107
-9,491
-9,413
-7,982
-6,264
Total Expenses
11,158
10,530
10,363
9,517
7,808
Net Income from Continuing & Discontinued Operation
-11,030
-9,927
-10,690
-9,312
-7,044
Normalized Income
-12,178
-11,075
-10,690
-9,312
-7,044
Interest Income
27
41
4
152
422
Interest Expense
2,098
1,625
1,281
1,488
1,202
Net Interest Income
-2,071
-1,584
-1,277
-1,336
-780
EBIT
-8,932
-8,302
-9,409
-7,830
-5,842
EBITDA
-8,156
-7,536
-8,632
-7,039
-5,108
Reconciled Cost of Revenue
1,745
1,733
1,858
2,256
1,477
Reconciled Depreciation
776
766
777
791
734
Net Income from Continuing Operation Net Minority Interest
-11,030
-9,927
-10,690
-9,312
-7,044
Total Unusual Items Excluding Goodwill
1,148
1,148
0
--
--
Total Unusual Items
1,148
1,148
0
--
--
Normalized EBITDA
-9,304
-8,684
-8,632
-7,039
-5,108
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2020 - 1/17/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AMBS Amarantus BioScience Holdings, Inc.
0.0003
0.00%
 
STMM Stemcell Holdings, Inc.
0.0600
0.00%
 
TGRP TRON Group Inc.
0.0350
-7.89%
 
APLMW Apollomics, Inc.
0.0150
+0.67%
 
AIBT Aibotics Inc.
0.0130
-55.17%
 
IBOGF Universal Ibogaine Inc.
0.0220
-26.67%
 
IMUC EOM Pharmaceuticals Holdings, Inc.
0.0950
0.00%
 
GBIO Generation Bio Co.
0.4019
+0.02%
 
TSBX Turnstone Biologics Corp.
0.3459
+1.11%
 
AGNPF Algernon Pharmaceuticals Inc.
0.0520
-11.86%